Centessa Pharmaceuticals plc CNTA
40.50 USD 0.00 (+0.00%)
At closeJun 25, 2026, 4:00 PM EDT
40.68 +0.18 +0.45%
After hours · Jun 25, 4:00 PM ET
40.50 Day range 40.50
52-week range unavailable
- YTD
- +61.94%
- 1 year
- +201.56%
Financial health
Altman Z-Score
20.83 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -17.1×
FY 2019 5y median -5.1× FY 2025
P/S 226×
FY 2019 5y median 0.0× FY 2025
P/B 6.4×
FY 2019 5y median 3.2× FY 2025
P/FCF -17.5×
FY 2019 5y median -7.4× FY 2025
EV/EBITDA -18.2×
FY 2019 5y median -4.4× FY 2025
EV/Sales 223×
FY 2019 5y median 0.0× FY 2025
FCF Yield -5.7%
FY 2019 5y median -13.5% FY 2025
Profitability
Gross Margin 100.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin -1384.6%
FY 2019 5y median 0.0% FY 2025
Net Margin -1316.9%
FY 2019 5y median 0.0% FY 2025
ROE -37.5%
FY 2019 5y median -64.0% FY 2025
ROIC -32.2%
FY 2019 5y median -45.8% FY 2025
ROA -28.7%
FY 2019 5y median -41.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -3.3%
FY 2019 FY 2025
EPS (diluted) 29.1%
FY 2019 FY 2025
Free Cash Flow -36.7%
FY 2019 FY 2025
Financial Health
Current Ratio 8.6×
FY 2019 5y median 9.2× FY 2025
Quick Ratio 8.6×
FY 2019 5y median 9.2× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 0.3×
FY 2019 5y median 1.2× FY 2025
Interest Coverage -18.1×
FY 2019 5y median -19.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31